Displaying One Session

08:45 - 10:15

Welcome and introduction (ID 4748)

MET pathway and overcoming MET resistance in NSCLC (ID 4749)

Designing a pragmatic strategy for targeting c-MET in NSCLC (ID 4750)

Applying a new mechanism of action and emerging predictive biomarker to inform precision treatment decisions in patients with advanced NSCLC (ID 4751)

Panel discussion and Q&A (ID 4752)

Summary and conclusions (ID 5540)